中性粒细胞/淋巴细胞比值与急性心肌梗死患者行急诊经皮冠状动脉介入治疗术后对比剂肾病发生的相关性The correlation between neutrophil/lymphocyte ratio and contrast-induced nephropathy after primary percutaneous coronary intervention in patients with acute myocardial infraction
叶飘,谭宁,陈纪言,刘勇,刘远辉,李华龙,蒋磊
摘要(Abstract):
目的探讨中性粒细胞/淋巴细胞比值(neutrophil/lymphocyte ratio,NLR)与急性ST段抬高心肌梗死(STEMI)患者行急诊经皮冠状动脉介入治疗(PCI)术后发生对比剂肾病(contrastinduced nephropathy,CIN)的相关性。方法入选500例行急诊PCI的患者,CIN定义为使用对比剂后48~72 h内血肌酸酐(肌酐)值较基线值升高超过44.2μmol/L或者较原基础值升高25%以上。比较CIN组与非CIN组之间的基线资料及院内不良临床事件发生率。采用受试者工作特征(ROC)曲线及Logistics回归分析评估NLR与CIN风险的相关性。结果 500例患者中,85例(17%)患者发生CIN。CIN组在院内死亡、需要肾脏替代治疗、需使用主动脉内球囊反搏、围术期低血压、急性心力衰竭、新发心律失常等院内不良事件的发生率均较非CIN组明显升高,差异有统计学意义。ROC曲线显示:NLR界值为6.03时,其预测CIN的敏感度为80.1%,特异度为73.7%,曲线下面积0.764。单因素Logistics回归分析显示,NLR水平与CIN发病率明显相关(OR 1.2,95%CI 1.1~1.3,P<0.01)。多因素Logistic回归分析显示,NLR>6.03是CIN的独立危险因素(OR 1.3,95%CI1.2~1.3,P<0.001);此外,女性、基础肾功能不全及围术期低血压也是CIN的独立危险因素(P<0.05)。结论急性STEMI患者行急诊PCI术前NLR水平与CIN相关,NLR升高的患者发生CIN的风险明显增高。
关键词(KeyWords): 中性粒细胞/淋巴细胞比值;对比剂;肾病;经皮冠状动脉介入治疗
基金项目(Foundation): 国家自然科学基金(81270286)
作者(Author): 叶飘,谭宁,陈纪言,刘勇,刘远辉,李华龙,蒋磊
参考文献(References):
- [1]Nash K,Hafeez A,Hou S.Hospital-acquired renal insuffi ciency.Am J Kidney Dis,2002,39:930-936.
- [2]Marenzi G,Lauri G,Assanelli E,et al.Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.J Am Coll Cardiol,2004,44:1780-1785.
- [3]Senoo T,Motohiro M,Kamihata H,et al.Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome.Am J Cardiol,2010,105:624-628.
- [4]Rihal CS,Textor SC,Grill DE,et al.Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention.Circulation,2002,105:2259-2264.
- [5]Alharazy SM,Kong N,Saidin R,et al.Serum Neutrophil GelatinaseAssociated Lipocalin and Cystatin C are early Biomarkers of Contrast-Induced Nephropathy After Coronary Angiography in Patients With Chronic Kidney Disease.Angiology,2013,[Epub ahead of print].
- [6]Liu Y,Tan N,Zhou YL,et al.High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.J Nephrol,2012,25:332-340.
- [7]何谊婷,谭宁,刘远辉,等.高敏C反应蛋白与经皮冠状动脉介入治疗患者对比剂肾病的相关性.中华心血管病杂志,2013,41:394-398.
- [8]姚友杰,杨敏华,许炳灿,等.血清尿酸、胆红素和超敏C反应蛋白与冠状动脉病变程度关系研究.中国介入心脏病学杂志,2008,6:323-327.
- [9]Sahin DY,Elbasan Z,Gur M,et al.Neutrophil to lymphocyte ratio is associated with the severity of coronary artery disease in patients with ST-segment elevation myocardial infarction.Angiology,2013,64:423-429.
- [10]Steg PG,James SK,Atar D,et al.ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.Eur Heart J,2012,33:2569-2619.
- [11]National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratifi cation.Am J Kidney Dis,2002,39:S1-S266.
- [12]Seeliger E,Sendeski M,Rihal CS,et al.Contrast-induced kidney injury:mechanisms,risk factors,and prevention.Eur Heart J,2012,33:2007-2015.
- [13]Libby P,Ridker PM,Hansson GK.Inflammation in AtherosclerosisFrom Pathophysiology to Practice.J Am Coll Cardiol,2009,54:2129-2138.
- [14]Oda E,Kawai R,Aizawa Y.Lymphocyte count was significantly associated with hyper-LDL cholesterolemia independently of highsensitivity C-reactive protein in apparently healthy Japanese.Heart Vessels,2012,27:377-383.
- [15]Horne BD,Anderson JL,John JM,et al,et al.Which white blood cellsubtypes predict increased cardiovascular risk?J Am Coll Cardiol,2005,45:1638-1643.
- [16]Fowler AJ,Agha RA.Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography--the growing versatility of NLR.Atherosclerosis,2013,228:44-45.
- [17]Kaya A,Kurt M,Tanboa IH.Neutrophil-to-Lymphocyte Ratio Predicts Contrast-Induced Nephropathy in Patients Undergoing Primary Percutaneous Coronary Intervention.Angiology,2013,Epub 2013 Sep 18.
- [18]Su JZ,Xue Y,Cai WQ,et al.[Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention:impact of atorvastatin].Zhonghua Xin Xue Guan Bing Za Zhi,2011,39:807-811.
- [19]Gao F,Zhou YJ,Zhu X,et al.C-reactive protein and the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.Am J Nephrol,2011,34:203-210.